1040682-46-9Relevant academic research and scientific papers
Quinazolinone Compound and Application Thereof
-
Paragraph 0534-0536, (2020/11/27)
The present invention relates to a series of quinazolinone compounds and applications thereof as PI3Kα inhibitors. In particular, the present invention relates to a compound shown in formula (I) and a tautomer or pharmaceutically acceptable salt thereof.
HETEROARYLS AND USES THEREOF
-
Paragraph 0245, (2016/12/01)
The present invention provides a compound of formula I: wherein R1, X1, X2, R2, R3, R4, R5, n, and m are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
HETEROARYLS AND USES THEREOF
-
Paragraph 00128, (2015/08/03)
The present invention provides a compound of formula I: wherein R1, X1, X2,R2, R3, R4, R5, n, and m are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
-
Page/Page column 243, (2010/12/18)
The invention is directed to compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
